Cancer stem cells (CSCs) are involved in tumor progression and drug resistance. We hypothesized that variants in CSC marker genes influence treatment outcomes in prostate cancer. | Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer